- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
Biogen (BIIB): Why Aducanumab Excitement Might Be Overblown
Biogen Inc (BIIB) recently shot up after reporting positive results from aducanumab’s phase 1b study. However, there are some important takeaways from the report that…
5 Stocks With Awful Earnings Momentum — LVNTA WRK CZR GLP RGSE
This week, these five stocks have the worst ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.
After Patent News, Aurinia Pharmaceuticals Still Has More to Prove
Is Aurinia’s patent news a big deal or a modest advance? Here’s why investors have mixed feelings about AUPH stock.
Why Is Novavax (NVAX) Up 30% Today?
While Novavax secured an agreement with the Canadian government over unused Covid-19 vaccines, NVAX stock remains risky.
Why Geron Corporation (GERN), Polaris Industries Inc. (PII) and VimpelCom Ltd (ADR) (VIP) Are 3 of Today’s Worst Stocks
Polaris (PII), VimpelCom (VIP) and Geron (GERN) were conspicuously left out of Monday’s rebound rally. Here’s what you need to know.
Trade of the Day: Micron Technology (MU)
A healthy dose of caution is always appropriate, which is why I continue to recommend short-term covered calls with a mix of long-term dividend names.
5 ETFs to Play Apple’s Big Rally
These five funds give you a big, low-cost dose of Apple stock exposure while also offering diversification across a number of other positions.
Europe, America Play Well Together — Thursday’s IP Market Recap
Stocks roared Thursday on a double dose of good news, from the ECB and on the U.S. jobs front. Also, Navistar and Men’s Wearhouse surged…
Novavax Looks Like a Winner With Its Vaccine Results
Novavax looks like a winner with its positive Covid-19 vaccine results. NVAX stock is worth at least 35% more than today based on widespread acceptance…
Avoid Novavax for Now, Until the Picture Clears Up
NVAX stock may have seen a near-term bounce following the completion of filing of EUA filing with the FDA, but it may not be a…
Ocugen Stock: The Two What-If Scenarios To Consider
OCGN stock is now facing an all or nothing business development and is at a very critical stage so it is wise to avoid it.
Why I’m Done With Novavax Stock
Management is terrible at delivering on its promises and even good news has failed to translate into higher prices for NVAX stock.
Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?
With a new Covid vaccine update today, how do the Moderna and Pfizer coronavirus vaccines compare? Dive in here.
NVAX Stock Alert: The Covid-19 Vaccine News Sending Novavax Higher Today
News that Australia has received its first shipment of Novavax’s Covid-19 vaccine has NVAX stock taking off nearly 9% in today’s trading.
Why Is Akero Therapeutics (AKRO) Stock Down 58% Today?
Akero Therapeutics (stock is falling hard on Tuesday after the company failed to impress AKRO investors with its clinical trial results.
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?
BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data.
Novavax Is Worth $165 Once Its Covid-19 Vaccine Is Ready
NVAX stock is set to move higher once its Covid-19 vaccine is ready. If its clinical trials succeed, NVAX stock is worth $165 per share,…
Moderna Stock Looks Too Cheap After This Recent Dip
Investors who enjoyed a five-fold return this year are selling now but more upside approaches as Moderna ships vaccines worldwide.
Developed World Boosters Offer Big Market for Eventual Novavax Vaccine
Novavax’s combination vaccine and its Covid-19 vaccine sales for Q1/2022 in Japan are positive drivers for its revenue in the years ahead.
Big Catalysts Are Just Around the Corner for iBio Stock
Asset prices don’t go up in a straight line, even if the company shows promise. Use the dip in IBIO stock now to get in…
Novavax Is Oversold, Time To Buy for Future Growth
NVAX stock seems oversold. Focus on low-income countries is likely to deliver revenue and cash flows from covid-19 vaccine sales in 2022.
Why Is GSE Systems (GVP) Stock Up 59% Today?
GSE Systems shares are rocketing higher on Friday despite a lack of news. However, GVP stock is seeing incredibly heavy trading this morning!
7 – 10 of 240 results
